Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. 1996

S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
Epstein-Barr Virus Unit, Queensland Institute of Medical Research, The Bancroft Centre, Brisbane, Australia.

The importance of cytotoxic T lymphocytes (CTLs) in the immunosurveillance of Epstein-Barr virus (EBV)-infected B cells is firmly established, and the viral antigens of CTL recognition in latent infection are well defined. The epitopes targeted by CTLs during primary infection have not been identified, however, and there is only limited information about T cell receptor (TCR) selection. In the present report, we have monitored the development of memory TCR-beta clonotypes selected in response to natural EBV infection in a longitudinal study of an HLA-B8+ individual with acute infectious mononucleosis (IM). By stimulating peripheral blood lymphocytes with HLA-B8+ EBV-transformed B lymphoblastoid cells, the primary virus-specific CTL response was shown to include specificities for two HLA-B8-restricted antigenic determinants, FLRGRAYGL and QAKWRLQTL, which are encoded within the latent EBV nuclear antigen EBNA-3. TCR-beta sequence analysis of CTL clones specific for each epitope showed polyclonal TCR-beta repertoire selection, with structural restrictions on recognition that indicated antigen-driven selection. Furthermore, longitudinal repertoire analysis revealed long-term preservation of a multiclonal effector response throughout convalescence, with the reemergence of distinct memory T cell clonotypes sharing similar structural restrictions. Tracking the progression of specific TCR-beta clonotypes and antigen-specific TCR-V beta family gene expression in the peripheral repertoire ex vivo using semiquantitative PCR strongly suggested that selective TCR-beta expansions were present at the clonotype level, but not at the TCR-V beta family level. Overall, in this first analysis of antigen-specific TCR development in IM, a picture of polyclonal TCR stimulation is apparent. This diversity may be especially important in the establishment of an effective CTL control during acute EBV infection and in recovery from disease.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D007244 Infectious Mononucleosis A common, acute infection usually caused by the Epstein-Barr virus (HERPESVIRUS 4, HUMAN). There is an increase in mononuclear white blood cells and other atypical lymphocytes, generalized lymphadenopathy, splenomegaly, and occasionally hepatomegaly with hepatitis. Glandular Fever,Mononucleosis, Infectious,Fever, Glandular
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
September 2012, Medical oncology (Northwood, London, England),
S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
October 1985, Clinical immunology and immunopathology,
S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
June 2001, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
March 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
June 2000, Current opinion in pediatrics,
S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
February 2001, Clinical otolaryngology and allied sciences,
S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
March 1971, Hippokrates,
S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
October 2004, American family physician,
S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
March 1993, Acta pathologica japonica,
S L Silins, and S M Cross, and S L Elliott, and S J Pye, and S R Burrows, and J M Burrows, and D J Moss, and V P Argaet, and I S Misko
September 1974, Human pathology,
Copied contents to your clipboard!